After obtaining informed consent from three patients with oestrogen and progesterone receptor positive and HER-2/neu negative invasive ductal adenocarcinoma of the breast, tissue specimens were obtained during breast tumour excision. Here, ERBB2 is linked to invasive ductal breast carcinoma.